Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235725 · ClinicalTrials.gov registry record
Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry
A clinical trial of Major Depression and Dysthymia, sponsored by OM1.
- Completed
- Registry status
- 953
- Enrollment target
- 2
- Study locations
NCT04235725 is a study of Major Depression and Dysthymia that has completed, run by OM1. The registered enrollment target is 953 participants, above the 293-participant average among 28 other Major Depression trials with a reported enrollment target (225% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04235725, a study of Major Depression and Dysthymia, has completed, sponsored by OM1.
- COMPLETED
- Registry status
- 953 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this pilot project is to demonstrate feasibility and value of collecting harmonized outcomes measures for major depressive disorder (MDD) in two registries and combining the data to support patient-centered outcomes research.
Conditions Studied
Interventions
- OTHER Harmonized Depression Outcome Measures
Study Locations (2)
District of Columbia
- American Psychiatric Association - Washington D.C.
Kentucky
- American Board of Family Medicine - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 953 participants |
| Start Date | 2020-03-15 |
| Est. Completion | 2021-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04235725
The ClinicalTrials.gov registry entry for NCT04235725 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 953 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 293-participant average among 28 other Major Depression trials with a reported enrollment target (225% higher). The listed sponsor is OM1, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Major Depression appearing as the primary indexed condition, and to 1 intervention - of which Harmonized Depression Outcome Measures is the first listed.
NCT04235725 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Kentucky.
Frequently Asked Questions
What is clinical trial NCT04235725 about?
NCT04235725 is a clinical study titled "Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry". The purpose of this pilot project is to demonstrate feasibility and value of collecting harmonized outcomes measures for major depressive disorder (MDD) in two registries and combining the data to support patient-centered outcomes research.
What is the current status of trial NCT04235725?
This trial is currently completed. The enrollment target is 953 participants. The study started on 2020-03-15. Estimated completion is 2021-05-15.
What conditions does trial NCT04235725 study?
This clinical trial studies the following conditions: Major Depression, Dysthymia.
What interventions are being tested in trial NCT04235725?
The interventions under investigation include: Harmonized Depression Outcome Measures (OTHER).
Who is sponsoring clinical trial NCT04235725?
This trial is sponsored by OM1, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04235725 being conducted?
This trial has 2 study locations across District of Columbia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
RECRUITING
-
Leucine in Midlife Depression
RECRUITING · Phase 2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.